FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+13.78%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.67B
AUM Growth
+$1.67B
(+11%)
Cap. Flow
-$18.2M
Cap. Flow
% of AUM
-1.09%
Top 10 Holdings %
Top 10 Hldgs %
44.6%
Holding
84
New
7
Increased
30
Reduced
18
Closed
5
Top Buys
| 1 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$26.3M |
| 2 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$18.5M |
| 3 |
Alphatec Holdings
ATEC
|
$15.4M |
| 4 |
Relay Therapeutics
RLAY
|
$14.3M |
| 5 |
Insmed
INSM
|
$12.4M |
Top Sells
| 1 |
Prothena Corp
PRTA
|
$51.8M |
| 2 |
CareDx
CDNA
|
$29M |
| 3 |
BioXcel Therapeutics
BTAI
|
$15.5M |
| 4 |
Maravai LifeSciences
MRVI
|
$12.1M |
| 5 |
Health Catalyst
HCAT
|
$11.5M |
Sector Composition
| 1 | Healthcare | 83.7% |
| 2 | Communication Services | 4.44% |
| 3 | Energy | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPNE
1
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $123M | 7.37% | 5,988,509 +562,268 | +10% | +$11.5M |
|
|
2
Prothena Corp
PRTA
$441M
| $99.1M | 5.95% | 1,927,829 -1,007,878 | -34% | -$51.8M |
|
3
Halozyme
HALO
$8.56B
| $93.1M | 5.59% | 2,050,273 +38,923 | +2% | +$1.77M |
|
|
4
CareDx
CDNA
$727M
| $82M | 4.92% | 896,257 -316,420 | -26% | -$29M |
|
|
MODN
5
DELISTED
MODEL N, INC.
MODN
| $74.1M | 4.44% | 2,161,936 +212,174 | +11% | +$7.27M |
|
6
AtriCure
ATRC
$1.84B
| $61.3M | 3.68% | 772,775 -55,227 | -7% | -$4.38M |
|
7
Omnicell
OMCL
$1.5B
| $57.7M | 3.46% | 381,145 +2,070 | +0.5% | +$313K |
|
8
NeoGenomics
NEO
$1.13B
| $51.9M | 3.11% | 1,148,945 +145,729 | +15% | +$6.58M |
|
9
Tandem Diabetes Care
TNDM
$845M
| $51.5M | 3.09% | 528,606 +3,477 | +0.7% | +$339K |
|
|
CUTR
10
DELISTED
Cutera, Inc.
CUTR
| $49.9M | 2.99% | 1,017,523 -226,594 | -18% | -$11.1M |
|
11
Axogen
AXGN
$743M
| $48M | 2.88% | 2,221,673 -335,739 | -13% | -$7.26M |
|
|
12
Health Catalyst
HCAT
$239M
| $43.8M | 2.63% | 789,393 -207,808 | -21% | -$11.5M |
|
|
ARNA
13
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $42.1M | 2.53% | 617,124 +270,850 | +78% | +$18.5M |
|
14
OptimizeRx
OPRX
$335M
| $41.2M | 2.47% | 664,842 +70,643 | +12% | +$4.37M |
|
|
15
Insmed
INSM
$28.8B
| $39.4M | 2.37% | 1,385,648 +434,695 | +46% | +$12.4M |
|
16
Aldeyra Therapeutics
ALDX
$351M
| $39.3M | 2.36% | 3,471,459 +847,458 | +32% | +$9.6M |
|
17
Arrowhead Research
ARWR
$3.05B
| $38.6M | 2.31% | 465,572 -71,264 | -13% | -$5.9M |
|
18
Sutro Biopharma
STRO
$72.7M
| $38.5M | 2.31% | 2,072,875 +14,428 | +0.7% | +$268K |
|
|
XENT
19
DELISTED
Intersect ENT, Inc
XENT
| $37.8M | 2.27% | 2,210,970 +174,325 | +9% | +$2.98M |
|
20
Krystal Biotech
KRYS
$4.27B
| $35.8M | 2.15% | 526,650 +35,139 | +7% | +$2.39M |
|
21
Glaukos
GKOS
$5.5B
| $34.7M | 2.08% | 409,144 -123,513 | -23% | -$10.5M |
|
22
Y-mAbs Therapeutics
YMAB
$388M
| $32.1M | 1.93% | 950,192 +5,939 | +0.6% | +$201K |
|
|
KRTX
23
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $31.3M | 1.88% | 274,780 +16,280 | +6% | +$1.86M |
|
|
TPTX
24
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $30.9M | 1.85% | 395,825 +336,946 | +572% | +$26.3M |
|
25
Teva Pharmaceuticals
TEVA
$21.1B
| $29.4M | 1.77% | 2,973,092 -701,012 | -19% | -$6.94M |
|